Albemarle Investor Presentation slide image

Albemarle Investor Presentation

Adjusted EBITDA - (twelve months ended) ($ in thousands) 2019 Year ended December 31, 2020 2021 2022 Net income attributable to Albemarle Corporation 533,228 375,764 123,672 Depreciation and amortization 213,484 231,984 254,000 2,689,816 300,841 Non-recurring and other unusual items (excluding items associated with interest expense) 117,243 42,781 481,194 28,671 Interest and financing expenses 57,695 73,116 61,476 122,973 Income tax expense 88,161 54,425 29,446 390,588 Non-operating pension and OPEB items 26,970 40,668 (78,814) (57,032) Adjusted EBITDA 1,036,781 818,738 870,974 $ 3,475,857 Net impact of adjusted EBITDA from divested businesses (49,628) (76,325) Adjusted EBITDA excluding impact from divested business $ 987,153 $ 742,413 $ (28,415) 842,559 $ 3,475,857 Net sales Net impact of net sales from divested business Net sales excluding impact from divested business 3,589,427 3,128,909 3,327,957 7,320,104 $ (165,224) 3,424,203 $ (201,311) 2,927,598 $ (65,648) 3,262,309 $ 7,320,104 Adjusted EBITDA margin excluding impact from divested businesses 29 % 25% 26 % 47 % See above for a reconciliation of EBITDA, adjusted EBITDA and the non-GAAP financial measures, to Net income attributable to Albemarle Corporation, the most directly comparable financial measure calculated and reported in accordance with GAAP. ALBEMARLE 38 38
View entire presentation